ARCHIVES

NCI Announces New CREG Offer For In Vitro Chemical Carcinogenesis Tests

This article is from The Cancer Letter archive.

Vol. 01 No. 47 | November 21, 1975

Download PDF Visit The Full Archive

Related Articles

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

February 3, 2006

NCI Programs: NCI Drug Screening To Take More Targeted Approach; BSA Okays Plan To Support New MA Contracts

April 3, 1998

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

Argentine Human Rights Violations Continue, But Some Improvement Seen

October 20, 1978

Garfinkel to Retire From ACS; Health to Succeed Him

July 20, 1990